Skip to main content
Fig. 6 | BMC Pulmonary Medicine

Fig. 6

From: Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial

Fig. 6

Relationship between selected cytokines and symptoms questionnaire, forced expiratory volume at first second (FEV1) and peripheral oxygen saturation (SpO2) in subjects with cystic fibrosis. Data correspond to all values observed at weeks 4 and 8, expressed as percentage of their respective baseline value at the beginning of the glycine or placebo period (week 0)

Back to article page